ZOLEDRONIC ACID

ZOLEDRONIC ACID was reported 40710 times

ZOLEDRONIC ACID is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ACUTE PHASE REACTION 138 0.3622
1 OSTEOPETROSIS 45 0.2866
2 BONE SEQUESTRUM 43 0.2829
3 PAROPHTHALMIA 61 0.2563
4 IDIOPATHIC ORBITAL INFLAMMATION 46 0.2396
5 OROANTRAL FISTULA 51 0.2350
6 WOUND CLOSURE 42 0.2165
7 JAW FISTULA 27 0.2077
8 PARATHYROID TUMOUR MALIGNANT 25 0.1953
9 AMAUROSIS FUGAX 195 0.1811
10 HYPERBARIC OXYGEN THERAPY 26 0.1566
11 ORAL CAVITY FISTULA 72 0.1472
12 OSTEOTOMY 48 0.1468
13 CARBOHYDRATE ANTIGEN 15-3 INCREASED 107 0.1406
14 PERIORBITAL INFLAMMATION 30 0.1299
15 OSTEONECROSIS OF EXTERNAL AUDITORY CANAL 24 0.1200
16 EXPOSED BONE IN JAW 250 0.1153
17 OSTEONECROSIS OF JAW 2774 0.1120
18 BONE DEBRIDEMENT 53 0.1097
19 SEQUESTRECTOMY 73 0.1093
20 PIK3CA-ACTIVATED MUTATION 33 0.0994
21 HORMONE RECEPTOR POSITIVE HER2 NEGATIVE BREAST CANCER 30 0.0904
22 ATYPICAL FEMUR FRACTURE 253 0.0896
23 ATYPICAL FRACTURE 51 0.0828
24 DEBRIDEMENT 62 0.0806
25 PRIMARY SEQUESTRUM 67 0.0740
26 ACTINOMYCOSIS 69 0.0720
27 OSTEOLYSIS 136 0.0665
28 BONE LESION 237 0.0657
29 BONE MARROW INFILTRATION 24 0.0620
30 METASTASES TO BONE 951 0.0579
31 OSTEOSCLEROSIS 87 0.0552
32 METASTASES TO SPINE 183 0.0544
33 RESPIRATORY TRACT INFECTION BACTERIAL 27 0.0542
34 METASTASES TO BONE MARROW 27 0.0540
35 FANCONI SYNDROME 76 0.0537
36 IRIDOCYCLITIS 161 0.0509
37 METASTASES TO PELVIS 32 0.0506
38 GIANT CELL ARTERITIS 40 0.0481
39 URINARY TRACT DISORDER 207 0.0459
40 PLEURAL THICKENING 31 0.0453
41 MYOGLOBINURIA 24 0.0450
42 JAW OPERATION 40 0.0450
43 CELLULITIS ORBITAL 26 0.0446
44 METASTASES TO SKIN 46 0.0445
45 METASTASES TO PLEURA 46 0.0439
46 FRACTURE NONUNION 59 0.0431
47 CHONDROCALCINOSIS 28 0.0429
48 SCLERITIS 64 0.0399
49 CHONDROCALCINOSIS PYROPHOSPHATE 30 0.0388
50 JAW DISORDER 212 0.0387
51 BLOOD MAGNESIUM INCREASED 33 0.0366
52 PATHOLOGICAL FRACTURE 183 0.0360
53 ADRENOCORTICAL INSUFFICIENCY ACUTE 70 0.0358
54 HYPOPHOSPHATAEMIA 264 0.0357
55 ABSCESS JAW 37 0.0356
56 HYPOCALCAEMIA 628 0.0331
57 PERIODONTAL DISEASE 45 0.0321
58 OSTEONECROSIS 1033 0.0314
59 FANCONI SYNDROME ACQUIRED 55 0.0313
60 TONSILLAR DISORDER 35 0.0311
61 ABDOMINAL LYMPHADENOPATHY 27 0.0311
62 GINGIVAL INFECTION 25 0.0310
63 JAW FRACTURE 66 0.0306
64 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 38 0.0305
65 EXCESSIVE GRANULATION TISSUE 24 0.0298
66 BREAST CANCER METASTATIC 320 0.0298
67 METASTASES TO ADRENALS 27 0.0293
68 BONE DISORDER 527 0.0289
69 PERIODONTITIS 62 0.0286
70 HAEMORRHAGIC STROKE 222 0.0284
71 ULNA FRACTURE 28 0.0283
72 BONE PAIN 1623 0.0277
73 METASTASES TO LYMPH NODES 185 0.0274
74 LOOSE TOOTH 88 0.0273
75 BREAST CANCER RECURRENT 86 0.0272
76 TOOTH EXTRACTION 336 0.0270
77 PAIN IN JAW 762 0.0269
78 IRITIS 80 0.0263
79 METASTASES TO LIVER 452 0.0257
80 BONE SWELLING 24 0.0248
81 PLEURAL FIBROSIS 25 0.0245
82 STRESS FRACTURE 132 0.0244
83 CONJUNCTIVAL OEDEMA 25 0.0243
84 LYMPHADENOPATHY MEDIASTINAL 46 0.0240
85 OSTEITIS 60 0.0238
86 MEAN CELL HAEMOGLOBIN INCREASED 39 0.0235
87 INVASIVE DUCTAL BREAST CARCINOMA 64 0.0235
88 METASTASES TO LUNG 270 0.0233
89 CARCINOEMBRYONIC ANTIGEN INCREASED 45 0.0232
90 PERIPHERAL SENSORIMOTOR NEUROPATHY 29 0.0231
91 COMPRESSION FRACTURE 121 0.0226
92 PURULENT DISCHARGE 93 0.0217
93 MASTICATION DISORDER 65 0.0212
94 CANCER PAIN 54 0.0211
95 ONYCHOLYSIS 33 0.0211
96 BLOOD CALCIUM DECREASED 234 0.0208
97 OSTEOMALACIA 32 0.0207
98 GINGIVAL SWELLING 91 0.0206
99 OCULAR DISCOMFORT 228 0.0203
100 HORMONE-REFRACTORY PROSTATE CANCER 24 0.0202
101 HYPERCALCAEMIA 241 0.0195
102 LIMB DEFORMITY 31 0.0195
103 CONCOMITANT DISEASE PROGRESSION 38 0.0194
104 HEPATIC LESION 84 0.0194
105 HYPERPARATHYROIDISM 40 0.0194
106 FEMUR FRACTURE 601 0.0194
107 BODY MASS INDEX INCREASED 26 0.0192
108 RENAL TUBULAR NECROSIS 186 0.0189
109 RESPIRATORY TRACT INFECTION VIRAL 44 0.0189
110 BLOOD PHOSPHORUS DECREASED 69 0.0189
111 TUMOUR MARKER INCREASED 89 0.0185
112 ORAL SURGERY 43 0.0184
113 PROSTATE CANCER METASTATIC 61 0.0182
114 HEPATIC MASS 35 0.0182
115 GENERALISED OEDEMA 221 0.0178
116 CALCIUM DEFICIENCY 23 0.0177
117 DENTAL IMPLANTATION 29 0.0177
118 HYPERPYREXIA 75 0.0177
119 BLOOD CALCIUM ABNORMAL 29 0.0174
120 THORACIC VERTEBRAL FRACTURE 51 0.0172
121 HYPERPARATHYROIDISM SECONDARY 43 0.0171
122 PURULENCE 33 0.0169
123 NASAL DISORDER 45 0.0169
124 MEAN CELL VOLUME INCREASED 43 0.0167
125 RADIUS FRACTURE 40 0.0166
126 TIBIA FRACTURE 78 0.0166
127 LOW TURNOVER OSTEOPATHY 65 0.0163
128 METASTASES TO PERITONEUM 41 0.0162
129 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 62 0.0162
130 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 23 0.0160
131 SPINAL PAIN 187 0.0159
132 LUMBAR VERTEBRAL FRACTURE 73 0.0159
133 DENTAL OPERATION 39 0.0158
134 INFLUENZA LIKE ILLNESS 1286 0.0156
135 INTRAMEDULLARY ROD INSERTION 32 0.0156
136 MUSCULOSKELETAL CHEST PAIN 238 0.0154
137 SPINAL COMPRESSION FRACTURE 127 0.0153
138 FIBULA FRACTURE 44 0.0153
139 TENOSYNOVITIS 42 0.0152
140 PELVIC FRACTURE 117 0.0150
141 METASTASIS 105 0.0147
142 OSTEOPOROTIC FRACTURE 28 0.0146
143 TEMPOROMANDIBULAR JOINT SYNDROME 39 0.0146
144 OSTEOMYELITIS 263 0.0145
145 BLOOD PARATHYROID HORMONE INCREASED 42 0.0144
146 EXOPHTHALMOS 31 0.0144
147 HEAD DISCOMFORT 254 0.0143
148 METASTASES TO CENTRAL NERVOUS SYSTEM 185 0.0143
149 FRACTURE 270 0.0142
150 PROSTATIC SPECIFIC ANTIGEN INCREASED 196 0.0142
151 KYPHOSIS 25 0.0141
152 GROIN PAIN 124 0.0141
153 TOOTHACHE 252 0.0139
154 WOUND DEHISCENCE 47 0.0139
155 SPINAL CORD COMPRESSION 54 0.0139
156 TETANY 25 0.0137
157 HAEMATOTOXICITY 130 0.0137
158 TOOTH DISORDER 303 0.0136
159 ENDODONTIC PROCEDURE 34 0.0134
160 NEOPLASM PROGRESSION 466 0.0134
161 PHOTOPHOBIA 234 0.0124
162 RENAL TUBULAR ACIDOSIS 27 0.0124
163 POLYMYALGIA RHEUMATICA 39 0.0123
164 MALIGNANT NEOPLASM PROGRESSION 1226 0.0120
165 GINGIVAL DISORDER 46 0.0120
166 EYE INFLAMMATION 114 0.0119
167 SPINAL FRACTURE 239 0.0119
168 OSTEOPENIA 178 0.0117
169 CALCINOSIS 26 0.0116
170 RED CELL DISTRIBUTION WIDTH INCREASED 48 0.0115
171 METASTASES TO MENINGES 26 0.0114
172 CHILLS 1319 0.0112
173 TRISMUS 58 0.0112
174 HYDRONEPHROSIS 84 0.0112
175 MYALGIA 1907 0.0112
176 DIPLOPIA 291 0.0112
177 GINGIVITIS 60 0.0111
178 CREATININE RENAL CLEARANCE DECREASED 44 0.0110
179 ALTERED STATE OF CONSCIOUSNESS 238 0.0110
180 NEUTROPHIL COUNT ABNORMAL 31 0.0110
181 DECREASED IMMUNE RESPONSIVENESS 106 0.0108
182 SKIN TOXICITY 61 0.0108
183 BLOOD CREATININE ABNORMAL 37 0.0107
184 BREATH ODOUR 26 0.0107
185 BLOOD PRESSURE DIASTOLIC ABNORMAL 27 0.0106
186 PRESYNCOPE 258 0.0106
187 HUMERUS FRACTURE 51 0.0106
188 GINGIVAL PAIN 84 0.0105
189 BLOOD CREATININE DECREASED 33 0.0105
190 NEUTROPENIA 1428 0.0105
191 BLOOD CALCIUM INCREASED 92 0.0105
192 BONE DENSITY ABNORMAL 39 0.0104
193 WEIGHT BEARING DIFFICULTY 28 0.0104
194 PATELLA FRACTURE 24 0.0103
195 PARONYCHIA 45 0.0102
196 OSTEOPOROSIS 421 0.0102
197 COMPUTERISED TOMOGRAM ABNORMAL 23 0.0101
198 BLOOD PRESSURE SYSTOLIC ABNORMAL 25 0.0101
199 TOOTH ABSCESS 101 0.0099
200 TOOTH FRACTURE 109 0.0099
201 EYE PAIN 557 0.0099
202 WALKING AID USER 65 0.0098
203 FISTULA 110 0.0098
204 ORAL INFECTION 38 0.0097
205 ASCITES 284 0.0097
206 DYSCHEZIA 29 0.0095
207 LUNG CANCER METASTATIC 27 0.0094
208 LYMPHOEDEMA 64 0.0092
209 LUMBAR SPINAL STENOSIS 27 0.0092
210 PLASMA CELL MYELOMA RECURRENT 30 0.0092
211 GLOMERULAR FILTRATION RATE DECREASED 113 0.0092
212 UVEITIS 124 0.0091
213 ORAL DISORDER 67 0.0091
214 VITAMIN D DEFICIENCY 89 0.0091
215 DEAFNESS NEUROSENSORY 30 0.0091
216 HAEMATEMESIS 231 0.0091
217 FOOT FRACTURE 171 0.0090
218 POLYARTHRITIS 47 0.0089
219 MUCOSAL INFLAMMATION 232 0.0089
220 THERAPY PARTIAL RESPONDER 138 0.0088
221 WRIST FRACTURE 105 0.0088
222 RIB FRACTURE 180 0.0087
223 FACIAL PAIN 77 0.0086
224 NECK PAIN 480 0.0086
225 URINE OUTPUT DECREASED 75 0.0086
226 OEDEMA MOUTH 28 0.0086
227 PERIPHERAL SENSORY NEUROPATHY 50 0.0085
228 PROTEIN TOTAL DECREASED 32 0.0085
229 RED BLOOD CELL SEDIMENTATION RATE INCREASED 94 0.0085
230 TOOTH LOSS 175 0.0084
231 BLOOD CREATININE INCREASED 550 0.0084
232 BLOOD UREA INCREASED 141 0.0084
233 ABASIA 207 0.0084
234 MOVEMENT DISORDER 269 0.0084
235 BEDRIDDEN 110 0.0084
236 MUSCULOSKELETAL DISCOMFORT 144 0.0084
237 ATYPICAL PNEUMONIA 25 0.0084
238 CLAVICLE FRACTURE 32 0.0083
239 PYREXIA 2875 0.0083
240 ORAL PAIN 186 0.0083
241 JOINT EFFUSION 57 0.0083
242 HAEMATURIA 283 0.0083
243 MONOCYTE COUNT INCREASED 30 0.0083
244 BLOOD ALKALINE PHOSPHATASE INCREASED 202 0.0081
245 MUSCULOSKELETAL PAIN 426 0.0081
246 HIP FRACTURE 261 0.0081
247 POLYNEUROPATHY 97 0.0081
248 TENDERNESS 84 0.0081
249 DENTAL CARIES 88 0.0079
250 VITAMIN D DECREASED 68 0.0079
251 ARTHRALGIA 3282 0.0079
252 SPINAL OSTEOARTHRITIS 69 0.0078
253 POLYDIPSIA 31 0.0078
254 PULMONARY MASS 116 0.0078
255 BREAST MASS 52 0.0077
256 VULVOVAGINAL DRYNESS 25 0.0077
257 HAEMATOCRIT DECREASED 153 0.0077
258 PLASMA CELL MYELOMA 300 0.0077
259 IMPAIRED HEALING 251 0.0076
260 NEUTROPHIL COUNT DECREASED 311 0.0076
261 FIBRIN D DIMER INCREASED 27 0.0076
262 CACHEXIA 39 0.0076
263 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 176 0.0075
264 CUSHINGOID 24 0.0075
265 HYPOMAGNESAEMIA 104 0.0075
266 HYPOKINESIA 108 0.0074
267 CUTANEOUS VASCULITIS 27 0.0074
268 BODY TEMPERATURE INCREASED 149 0.0073
269 SPINAL DISORDER 69 0.0073
270 WOUND COMPLICATION 25 0.0073
271 TINNITUS 332 0.0072
272 NEPHROPATHY TOXIC 81 0.0072
273 BLINDNESS 292 0.0072
274 FLANK PAIN 67 0.0071
275 EXOSTOSIS 65 0.0071
276 CEREBRAL ATROPHY 28 0.0070
277 LEUKOPENIA 348 0.0070
278 TOOTH INFECTION 91 0.0069
279 BONE CANCER 30 0.0069
280 HEPATOTOXICITY 153 0.0069
281 OSTEOARTHRITIS 291 0.0069
282 MUSCLE FATIGUE 29 0.0068
283 NEUROPATHY PERIPHERAL 650 0.0068
284 INFUSION SITE SWELLING 43 0.0068
285 BACK PAIN 1581 0.0068
286 ELECTROLYTE IMBALANCE 79 0.0068
287 HAND FRACTURE 48 0.0068
288 METASTATIC NEOPLASM 29 0.0067
289 SYNOVIAL CYST 31 0.0067
290 MULTIPLE FRACTURES 110 0.0067
291 DYSSTASIA 195 0.0067
292 MULTIPLE MYELOMA 31 0.0066
293 HYPERTRANSAMINASAEMIA 46 0.0066
294 VEIN DISORDER 33 0.0066
295 OESOPHAGEAL PAIN 26 0.0066
296 FEMORAL NECK FRACTURE 33 0.0064
297 C-REACTIVE PROTEIN INCREASED 234 0.0064
298 INFUSION SITE EXTRAVASATION 40 0.0064
299 EPIGASTRIC DISCOMFORT 25 0.0064
300 ANKLE FRACTURE 99 0.0064
301 URINE ABNORMALITY 29 0.0064
302 HAEMOGLOBIN ABNORMAL 41 0.0064
303 HYPOKALAEMIA 292 0.0063
304 BONE LOSS 95 0.0063
305 RED BLOOD CELL COUNT DECREASED 180 0.0063
306 TUMOUR LYSIS SYNDROME 55 0.0062
307 ANAEMIA 1190 0.0062
308 LOWER LIMB FRACTURE 119 0.0062
309 DEAFNESS UNILATERAL 34 0.0062
310 CONCOMITANT DISEASE AGGRAVATED 38 0.0062
311 SPINAL COLUMN STENOSIS 29 0.0061
312 SECOND PRIMARY MALIGNANCY 51 0.0061
313 ATELECTASIS 59 0.0061
314 BLOOD CREATINE INCREASED 27 0.0061
315 QUALITY OF LIFE DECREASED 81 0.0060
316 DIVERTICULUM INTESTINAL 26 0.0059
317 INTERVERTEBRAL DISC DEGENERATION 55 0.0059
318 STREPTOCOCCAL INFECTION 33 0.0059
319 BLOOD ALBUMIN DECREASED 47 0.0059
320 DERMATITIS ACNEIFORM 36 0.0059
321 NEUTROPENIC SEPSIS 42 0.0059
322 CARDIAC FAILURE CHRONIC 25 0.0059
323 EXTRAVASATION 24 0.0058
324 THROMBOCYTOPENIA 653 0.0058
325 APHAGIA 28 0.0058
326 INFLAMMATION 300 0.0058
327 DECREASED APPETITE 1350 0.0058
328 BLOOD PRESSURE SYSTOLIC INCREASED 113 0.0058
329 BLOOD MAGNESIUM DECREASED 50 0.0058
330 PAIN IN EXTREMITY 1707 0.0058
331 PERFORMANCE STATUS DECREASED 27 0.0058
332 HYPOGAMMAGLOBULINAEMIA 38 0.0058
333 ANAL INCONTINENCE 52 0.0058
334 FULL BLOOD COUNT ABNORMAL 61 0.0058
335 TUBULOINTERSTITIAL NEPHRITIS 108 0.0058
336 DISEASE PROGRESSION 681 0.0057
337 WHITE BLOOD CELL COUNT DECREASED 623 0.0057
338 MOUTH ULCERATION 121 0.0057
339 CARDIO-RESPIRATORY ARREST 238 0.0057
340 PARAESTHESIA ORAL 82 0.0057
341 MUSCLE DISORDER 46 0.0057
342 NODULE 74 0.0057
343 ONYCHOCLASIS 39 0.0057
344 RENAL CYST 45 0.0057
345 PNEUMONITIS 154 0.0057
346 LYMPHADENOPATHY 198 0.0056
347 MOUTH SWELLING 32 0.0055
348 UROSEPSIS 51 0.0055
349 SCOLIOSIS 34 0.0055
350 SQUAMOUS CELL CARCINOMA OF SKIN 33 0.0055
351 ACUTE KIDNEY INJURY 835 0.0055
352 ASPARTATE AMINOTRANSFERASE INCREASED 289 0.0054
353 BODY HEIGHT DECREASED 58 0.0054
354 RENAL IMPAIRMENT 453 0.0054
355 ASTHENIA 2016 0.0054
356 BRONCHIECTASIS 36 0.0053
357 PLEURAL EFFUSION 324 0.0053
358 HEPATIC STEATOSIS 99 0.0053
359 RESPIRATORY TRACT INFECTION 138 0.0053
360 INTESTINAL ISCHAEMIA 29 0.0053
361 HYPOPHAGIA 134 0.0052
362 PAIN 3215 0.0052
363 GINGIVAL BLEEDING 71 0.0052
364 HAEMOGLOBIN DECREASED 533 0.0052
365 INFUSION RELATED REACTION 342 0.0052
366 PERIORBITAL SWELLING 29 0.0051
367 EYELID PTOSIS 52 0.0051
368 GAIT DISTURBANCE 978 0.0051
369 EAR PAIN 99 0.0051
370 LEFT VENTRICULAR DYSFUNCTION 34 0.0051
371 TACHYCARDIA 447 0.0050
372 SYNCOPE 503 0.0050
373 JOINT DISLOCATION 53 0.0050
374 RENAL PAIN 53 0.0050
375 FEBRILE NEUTROPENIA 331 0.0050
376 BLOOD POTASSIUM INCREASED 81 0.0050
377 MUSCULOSKELETAL STIFFNESS 437 0.0050
378 CYTOPENIA 61 0.0050
379 EATING DISORDER 106 0.0050
380 SEPSIS 555 0.0050
381 JOINT SWELLING 600 0.0050
382 RESPIRATORY RATE INCREASED 44 0.0050
383 UPPER LIMB FRACTURE 98 0.0049
384 BONE DENSITY DECREASED 154 0.0049
385 DECUBITUS ULCER 40 0.0049
386 BREAST PAIN 52 0.0049
387 ARTHRITIS 383 0.0049
388 RENAL FAILURE ACUTE 206 0.0048
389 ALANINE AMINOTRANSFERASE INCREASED 298 0.0048
390 FAILURE TO THRIVE 25 0.0048
391 NEUTROPHIL COUNT INCREASED 49 0.0048
392 ORAL CANDIDIASIS 63 0.0048
393 HYPERCHOLESTEROLAEMIA 46 0.0048
394 LYMPHOCYTE COUNT DECREASED 84 0.0047
395 ATRIAL FIBRILLATION 462 0.0047
396 BLOOD PRESSURE DIASTOLIC DECREASED 35 0.0047
397 FEELING COLD 132 0.0047
398 PERICARDIAL EFFUSION 109 0.0047
399 HIP ARTHROPLASTY 72 0.0047
400 TASTE DISORDER 95 0.0047
401 JOINT STIFFNESS 122 0.0046
402 EJECTION FRACTION DECREASED 72 0.0046
403 PLATELET COUNT ABNORMAL 28 0.0046
404 BLOOD PRESSURE INCREASED 707 0.0046
405 BLOOD LACTATE DEHYDROGENASE INCREASED 73 0.0046
406 INFUSION SITE PAIN 59 0.0046
407 PELVIC PAIN 83 0.0046
408 JOINT RANGE OF MOTION DECREASED 61 0.0045
409 WHITE BLOOD CELL COUNT ABNORMAL 29 0.0045
410 HYPOALBUMINAEMIA 35 0.0045
411 ACTIVITIES OF DAILY LIVING IMPAIRED 89 0.0045
412 PROTEINURIA 85 0.0045
413 BLOOD SODIUM DECREASED 84 0.0045
414 COMA 212 0.0044
415 ABSCESS 71 0.0044
416 VOMITING 2091 0.0044
417 SINUS TACHYCARDIA 63 0.0044
418 CYST 55 0.0044
419 MENISCUS INJURY 27 0.0044
420 DERMATITIS 92 0.0044
421 FALL 1459 0.0044
422 MALNUTRITION 49 0.0044
423 ENTERITIS 28 0.0044
424 DIVERTICULUM 31 0.0044
425 PLATELET COUNT DECREASED 464 0.0043
426 HYPERLIPIDAEMIA 52 0.0043
427 OEDEMA PERIPHERAL 529 0.0043
428 REBOUND EFFECT 49 0.0043
429 SCIATICA 69 0.0043
430 ANURIA 37 0.0043
431 OPTIC NEURITIS 39 0.0043
432 UPPER RESPIRATORY TRACT INFECTION 198 0.0043
433 TACHYPNOEA 58 0.0043
434 PARALYSIS 61 0.0043
435 CONJUNCTIVITIS 79 0.0043
436 HYPOAESTHESIA ORAL 64 0.0042
437 BLOOD THYROID STIMULATING HORMONE INCREASED 39 0.0042
438 URINARY INCONTINENCE 125 0.0042
439 OESOPHAGITIS 46 0.0042
440 BURSITIS 51 0.0042
441 CHEST PAIN 769 0.0041
442 STRESS CARDIOMYOPATHY 24 0.0041
443 APHTHOUS ULCER 32 0.0041
444 GENERAL PHYSICAL HEALTH DETERIORATION 474 0.0041
445 PANCYTOPENIA 228 0.0041
446 EYE INFECTION 46 0.0041
447 STOMATITIS 247 0.0041
448 GASTRITIS 107 0.0041
449 HYPERTHERMIA 31 0.0041
450 CHOLECYSTITIS ACUTE 23 0.0041
451 VENTRICULAR EXTRASYSTOLES 42 0.0040
452 EYE SWELLING 150 0.0040
453 BACTERIAL INFECTION 75 0.0040
454 MASS 56 0.0040
455 NEUROTOXICITY 70 0.0040
456 PERIPHERAL SWELLING 615 0.0040
457 GRIP STRENGTH DECREASED 35 0.0040
458 HYPOTHYROIDISM 127 0.0040
459 PAPULE 28 0.0040
460 SUPRAVENTRICULAR TACHYCARDIA 38 0.0040
461 HEPATOMEGALY 39 0.0040
462 MUSCLE SPASMS 727 0.0040
463 BLOOD BILIRUBIN INCREASED 107 0.0040
464 GAIT INABILITY 132 0.0039
465 HYPONATRAEMIA 221 0.0039
466 PNEUMONIA BACTERIAL 36 0.0039
467 DEHYDRATION 522 0.0039
468 POLYURIA 32 0.0039
469 OCULAR HYPERAEMIA 185 0.0039
470 ORAL DISCOMFORT 54 0.0039
471 HEADACHE 2430 0.0039
472 HIATUS HERNIA 50 0.0039
473 BODY TEMPERATURE DECREASED 38 0.0039
474 MUSCULAR WEAKNESS 438 0.0039
475 LIMB DISCOMFORT 119 0.0038
476 INFLUENZA 428 0.0038
477 BLOOD POTASSIUM DECREASED 115 0.0038
478 FULL BLOOD COUNT DECREASED 77 0.0038
479 ROTATOR CUFF SYNDROME 49 0.0038
480 MOBILITY DECREASED 274 0.0038
481 LEUKOCYTOSIS 69 0.0038
482 PRODUCT SUPPLY ISSUE 27 0.0038
483 DYSURIA 139 0.0038
484 URINARY TRACT INFECTION 640 0.0037
485 ACUTE CORONARY SYNDROME 31 0.0037
486 AUTOIMMUNE HEPATITIS 26 0.0037
487 CENTRAL NERVOUS SYSTEM LESION 51 0.0037
488 PHARYNGITIS 46 0.0037
489 DECREASED ACTIVITY 40 0.0037
490 BACTERAEMIA 44 0.0037
491 MUSCLE STRAIN 32 0.0037
492 FATIGUE 2876 0.0037
493 CONSTIPATION 802 0.0037
494 WHITE BLOOD CELL COUNT INCREASED 141 0.0037
495 POOR VENOUS ACCESS 38 0.0037
496 SWELLING 343 0.0037
497 MALAISE 1607 0.0037
498 PULMONARY EMBOLISM 347 0.0036
499 ESCHERICHIA INFECTION 30 0.0036
500 SKIN LESION 100 0.0036
501 PERIPHERAL COLDNESS 50 0.0036
502 HERPES ZOSTER 209 0.0036
503 NAUSEA 2876 0.0036
504 BLOOD DISORDER 29 0.0036
505 DIARRHOEA 2336 0.0036
506 HYPOAESTHESIA 541 0.0036
507 DIVERTICULITIS 100 0.0036
508 HYPERGLYCAEMIA 130 0.0036
509 NEOPLASM 41 0.0036
510 CELLULITIS 178 0.0035
511 CATARACT 210 0.0035
512 FACIAL PARALYSIS 30 0.0035
513 COUGH 982 0.0035
514 VERTIGO 213 0.0035
515 BONE MARROW FAILURE 71 0.0035
516 AUTOIMMUNE DISORDER 34 0.0035
517 OEDEMA 189 0.0035
518 VISION BLURRED 478 0.0035
519 SKIN DISORDER 116 0.0035
520 GAMMA-GLUTAMYLTRANSFERASE INCREASED 77 0.0035
521 LYMPHOPENIA 49 0.0035
522 MUSCLE TIGHTNESS 56 0.0035
523 NEURALGIA 84 0.0035
524 PARAESTHESIA 543 0.0034
525 DEAFNESS 90 0.0034
526 LETHARGY 198 0.0034
527 TENDON PAIN 26 0.0034
528 GASTROENTERITIS 50 0.0034
529 DYSPNOEA EXERTIONAL 129 0.0034
530 MYELOSUPPRESSION 123 0.0034
531 IMMUNE SYSTEM DISORDER 45 0.0034
532 LUNG INFECTION 53 0.0034
533 INCONTINENCE 36 0.0034
534 SEASONAL ALLERGY 48 0.0034
535 LIVER FUNCTION TEST INCREASED 72 0.0034
536 LOCALISED INFECTION 81 0.0033
537 MYOCARDIAL ISCHAEMIA 38 0.0033
538 NERVE INJURY 37 0.0033
539 BLADDER DISORDER 33 0.0033
540 NAIL DISORDER 29 0.0033
541 COVID-19 PNEUMONIA 39 0.0033
542 CIRCULATORY COLLAPSE 56 0.0033
543 BREAST CANCER 306 0.0033
544 TRANSAMINASES INCREASED 73 0.0033
545 CHROMATURIA 74 0.0033
546 PNEUMONIA 1060 0.0033
547 CHOLECYSTITIS 39 0.0033
548 LOCAL SWELLING 57 0.0033
549 ARTHROPATHY 181 0.0033
550 LOWER RESPIRATORY TRACT INFECTION 148 0.0033
551 IRON DEFICIENCY ANAEMIA 30 0.0032
552 MYOPATHY 28 0.0032
553 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 169 0.0032
554 RHINITIS 26 0.0032
555 FRUSTRATION TOLERANCE DECREASED 26 0.0032
556 ARTERIOSCLEROSIS 30 0.0032
557 DRUG-INDUCED LIVER INJURY 100 0.0032
558 HEART RATE IRREGULAR 72 0.0032
559 MITRAL VALVE INCOMPETENCE 36 0.0032
560 SKIN ULCER 82 0.0032
561 RENAL FAILURE 417 0.0031
562 LIGAMENT SPRAIN 31 0.0031
563 LIMB INJURY 85 0.0031
564 LACRIMATION INCREASED 94 0.0031
565 CHOLELITHIASIS 102 0.0031
566 DEFORMITY 29 0.0031
567 DEEP VEIN THROMBOSIS 201 0.0031
568 WEIGHT DECREASED 863 0.0031
569 HYPERBILIRUBINAEMIA 32 0.0031
570 BLOOD PRESSURE FLUCTUATION 74 0.0031
571 GASTROOESOPHAGEAL REFLUX DISEASE 248 0.0031
572 HAEMORRHOIDS 60 0.0031
573 HOT FLUSH 231 0.0031
574 ABDOMINAL PAIN 713 0.0031
575 ABDOMINAL PAIN UPPER 631 0.0031
576 FEELING ABNORMAL 733 0.0031
577 FEEDING DISORDER 62 0.0031
578 LUNG INFILTRATION 27 0.0031
579 HICCUPS 25 0.0030
580 FIBROMYALGIA 74 0.0030
581 HEPATIC FAILURE 91 0.0030
582 CYSTITIS 96 0.0030
583 EYE DISORDER 99 0.0030
584 ACIDOSIS 23 0.0030
585 CARDIOMEGALY 37 0.0030
586 INFECTION 435 0.0030
587 PYELONEPHRITIS 26 0.0030
588 CARPAL TUNNEL SYNDROME 42 0.0030
589 BRAIN FOG 47 0.0030
590 BLOOD TEST ABNORMAL 42 0.0030
591 CHEST DISCOMFORT 306 0.0030
592 BALANCE DISORDER 258 0.0030
593 DISSEMINATED INTRAVASCULAR COAGULATION 42 0.0030
594 BLOOD PRESSURE DECREASED 198 0.0030
595 PALLOR 81 0.0030
596 INTERVERTEBRAL DISC PROTRUSION 65 0.0030
597 TENDONITIS 46 0.0030
598 INSOMNIA 791 0.0030
599 BLOOD PRESSURE ABNORMAL 59 0.0030
600 RETCHING 63 0.0030
601 SURGERY 173 0.0029
602 POLLAKIURIA 123 0.0029
603 ANOREXIA 38 0.0029
604 IMMUNOSUPPRESSION 26 0.0029
605 DYSPNOEA 1668 0.0029
606 COAGULOPATHY 49 0.0029
607 DIZZINESS 1466 0.0029
608 DEATH 2523 0.0029
609 CLOSTRIDIUM DIFFICILE COLITIS 31 0.0029
610 GASTROINTESTINAL DISORDER 260 0.0029
611 MYOSITIS 26 0.0029
612 DYSPHAGIA 275 0.0029
613 NEPHROPATHY 27 0.0029
614 CARDIAC MURMUR 25 0.0029
615 PALPITATIONS 338 0.0029
616 IMMUNODEFICIENCY 43 0.0029
617 BURNING SENSATION 202 0.0029
618 BRONCHOSPASM 41 0.0029
619 SENSORY DISTURBANCE 46 0.0029
620 BLOOD URINE PRESENT 54 0.0028
621 MUSCLE ATROPHY 36 0.0028
622 EYELID OEDEMA 33 0.0028
623 PLATELET COUNT INCREASED 37 0.0028
624 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 29 0.0028
625 HYPERTENSION 598 0.0028
626 DISCOMFORT 172 0.0028
627 DIALYSIS 40 0.0028
628 URINARY RETENTION 94 0.0028
629 NERVE COMPRESSION 26 0.0028
630 CONFUSIONAL STATE 455 0.0028
631 LABORATORY TEST ABNORMAL 83 0.0028
632 JOINT INJURY 60 0.0028
633 MENTAL STATUS CHANGES 78 0.0028
634 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 48 0.0028
635 THIRST 50 0.0028
636 CONTUSION 268 0.0028
637 CEREBRAL INFARCTION 68 0.0028
638 BACK DISORDER 45 0.0028
639 PRODUCTIVE COUGH 132 0.0028
640 HYPERTHYROIDISM 40 0.0028
641 BASAL CELL CARCINOMA 43 0.0028
642 BRONCHITIS 204 0.0028
643 KNEE ARTHROPLASTY 58 0.0028
644 GLAUCOMA 53 0.0027
645 HEPATIC CYTOLYSIS 35 0.0027
646 ALOPECIA 538 0.0027
647 DEVICE RELATED INFECTION 42 0.0027
648 NEPHROLITHIASIS 125 0.0027
649 OROPHARYNGEAL PAIN 252 0.0027
650 GENERALISED TONIC-CLONIC SEIZURE 45 0.0027
651 LIVER FUNCTION TEST ABNORMAL 79 0.0027
652 LUNG DISORDER 133 0.0027
653 TEMPERATURE INTOLERANCE 28 0.0027
654 SEPTIC SHOCK 118 0.0027
655 MYELODYSPLASTIC SYNDROME 39 0.0027
656 SWELLING FACE 175 0.0027
657 DIZZINESS POSTURAL 26 0.0027
658 THYROID DISORDER 41 0.0027
659 PULMONARY FIBROSIS 51 0.0027
660 METABOLIC ACIDOSIS 85 0.0027
661 EPISTAXIS 198 0.0026
662 SUDDEN DEATH 28 0.0026
663 ELECTROCARDIOGRAM QT PROLONGED 95 0.0026
664 ULCER 42 0.0026
665 RASH PRURITIC 143 0.0026
666 RHINORRHOEA 170 0.0026
667 MUSCULOSKELETAL DISORDER 50 0.0026
668 SKIN REACTION 37 0.0026
669 GOUT 47 0.0026
670 FOOT DEFORMITY 29 0.0026
671 RETINAL DETACHMENT 24 0.0026
672 RENAL DISORDER 121 0.0026
673 INTERNATIONAL NORMALISED RATIO INCREASED 74 0.0026
674 DRY MOUTH 210 0.0026
675 SINUS DISORDER 51 0.0026
676 IMPAIRED WORK ABILITY 55 0.0026
677 DIARRHOEA HAEMORRHAGIC 24 0.0026
678 SPLENOMEGALY 30 0.0026
679 DRY THROAT 26 0.0026
680 UPPER GASTROINTESTINAL HAEMORRHAGE 43 0.0026
681 ADRENAL INSUFFICIENCY 31 0.0026
682 CHOLESTASIS 49 0.0025
683 IMPAIRED DRIVING ABILITY 29 0.0025
684 CANDIDA INFECTION 43 0.0025
685 COLITIS 96 0.0025
686 SMALL INTESTINAL OBSTRUCTION 31 0.0025
687 SUBDURAL HAEMATOMA 36 0.0025
688 HEART RATE INCREASED 249 0.0025
689 MACULAR DEGENERATION 30 0.0025
690 HEART RATE DECREASED 88 0.0025
691 DRY EYE 125 0.0025
692 SOMNOLENCE 504 0.0025
693 DISORIENTATION 99 0.0025
694 DRUG RESISTANCE 64 0.0025
695 JAUNDICE 67 0.0025
696 TRANSIENT ISCHAEMIC ATTACK 84 0.0025
697 VASCULITIS 29 0.0025
698 BLOOD CHOLESTEROL INCREASED 116 0.0025
699 UNRESPONSIVE TO STIMULI 64 0.0025
700 NOCTURIA 30 0.0025
701 DYSPEPSIA 243 0.0025
702 HEPATOCELLULAR INJURY 35 0.0025
703 NEOPLASM MALIGNANT 164 0.0025
704 GASTROINTESTINAL PAIN 27 0.0025
705 MOTOR DYSFUNCTION 25 0.0025
706 MICTURITION URGENCY 28 0.0024
707 FEELING HOT 150 0.0024
708 HYPOXIA 86 0.0024
709 COLD SWEAT 43 0.0024
710 RHABDOMYOLYSIS 101 0.0024
711 SKELETAL INJURY 25 0.0024
712 APHASIA 73 0.0024
713 RESPIRATORY FAILURE 176 0.0024
714 DEMENTIA 67 0.0024
715 KIDNEY INFECTION 47 0.0024
716 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 115 0.0024
717 SLEEP DISORDER 168 0.0024
718 FEAR 64 0.0024
719 VIRAL INFECTION 79 0.0024
720 DEVICE FAILURE 36 0.0024
721 ILLNESS 243 0.0024
722 NIGHT SWEATS 76 0.0024
723 VISUAL IMPAIRMENT 292 0.0024
724 MYOCARDITIS 27 0.0024
725 HYPERHIDROSIS 303 0.0023
726 POST PROCEDURAL COMPLICATION 45 0.0023
727 ACUTE RESPIRATORY FAILURE 45 0.0023
728 AGEUSIA 58 0.0023
729 INTESTINAL PERFORATION 26 0.0023
730 HEAD INJURY 73 0.0023
731 DELIRIUM 80 0.0023
732 RECTAL HAEMORRHAGE 99 0.0023
733 TREMOR 382 0.0023
734 ABDOMINAL DISCOMFORT 385 0.0023
735 PRODUCT USE IN UNAPPROVED INDICATION 568 0.0023
736 LIVER INJURY 56 0.0023
737 CHOLECYSTECTOMY 26 0.0023
738 RASH PAPULAR 51 0.0023
739 VISUAL ACUITY REDUCED 75 0.0023
740 DRUG ERUPTION 40 0.0023
741 SINUSITIS 231 0.0023
742 WOUND 63 0.0023
743 ABDOMINAL DISTENSION 235 0.0022
744 PRODUCT PRESCRIBING ISSUE 49 0.0022
745 LIVER DISORDER 99 0.0022
746 SKIN INFECTION 25 0.0022
747 DERMATITIS ALLERGIC 28 0.0022
748 PULMONARY CONGESTION 29 0.0022
749 COVID-19 385 0.0022
750 MULTIPLE ORGAN DYSFUNCTION SYNDROME 62 0.0022
751 HYPOTENSION 438 0.0022
752 POOR QUALITY SLEEP 47 0.0022
753 SHOCK 50 0.0022
754 PRURITUS 830 0.0022
755 HYPERTENSIVE CRISIS 24 0.0022
756 DEPRESSED MOOD 114 0.0022
757 ARRHYTHMIA 102 0.0022
758 APHONIA 30 0.0021
759 LOSS OF CONSCIOUSNESS 275 0.0021
760 THROMBOSIS 172 0.0021
761 SKIN DISCOLOURATION 98 0.0021
762 NO THERAPEUTIC RESPONSE 26 0.0021
763 OXYGEN SATURATION DECREASED 119 0.0021
764 MIGRAINE 202 0.0021
765 SWOLLEN TONGUE 66 0.0021
766 SYNOVITIS 38 0.0021
767 GASTRIC ULCER 40 0.0021
768 EYE HAEMORRHAGE 28 0.0021
769 ILEUS 26 0.0021
770 HEPATIC FUNCTION ABNORMAL 78 0.0021
771 RASH MACULO-PAPULAR 46 0.0021
772 SCAR 35 0.0020
773 ACUTE MYOCARDIAL INFARCTION 60 0.0020
774 DRUG INTERACTION 322 0.0020
775 OFF LABEL USE 1775 0.0020
776 HYPERSOMNIA 58 0.0020
777 DYSGEUSIA 150 0.0020
778 DRUG INTOLERANCE 195 0.0020
779 MALIGNANT MELANOMA 27 0.0020
780 RHEUMATOID ARTHRITIS 228 0.0020
781 HAEMATOMA 52 0.0020
782 MELAENA 44 0.0020
783 PHOTOSENSITIVITY REACTION 33 0.0020
784 ORAL HERPES 39 0.0020
785 APATHY 29 0.0020
786 ACUTE RESPIRATORY DISTRESS SYNDROME 35 0.0020
787 NASOPHARYNGITIS 363 0.0020
788 PERICARDITIS 33 0.0020
789 FACE OEDEMA 33 0.0020
790 NERVOUS SYSTEM DISORDER 61 0.0020
791 ERYTHEMA 400 0.0019
792 PROSTATE CANCER 156 0.0019
793 GASTROENTERITIS VIRAL 35 0.0019
794 CRYING 70 0.0019
795 BLOOD TRIGLYCERIDES INCREASED 34 0.0019
796 HYPOACUSIS 82 0.0019
797 PNEUMOTHORAX 30 0.0019
798 SPEECH DISORDER 99 0.0019
799 RASH 823 0.0019
800 ADVERSE REACTION 25 0.0019
801 INTERSTITIAL LUNG DISEASE 91 0.0019
802 PULMONARY OEDEMA 84 0.0019
803 AMNESIA 122 0.0019
804 CONDITION AGGRAVATED 570 0.0019
805 DIABETES MELLITUS INADEQUATE CONTROL 33 0.0019
806 HYPERSENSITIVITY 346 0.0019
807 SINUS CONGESTION 25 0.0018
808 DEPRESSION 421 0.0018
809 THROAT IRRITATION 83 0.0018
810 RESPIRATORY DISORDER 55 0.0018
811 HEPATITIS 47 0.0018
812 PANCREATITIS ACUTE 41 0.0018
813 SARS-COV-2 TEST POSITIVE 24 0.0018
814 RESTLESS LEGS SYNDROME 33 0.0018
815 CARDIOGENIC SHOCK 26 0.0018
816 DIABETES MELLITUS 138 0.0018
817 GASTRIC DISORDER 62 0.0018
818 HEPATIC ENZYME INCREASED 123 0.0018
819 HALLUCINATION, VISUAL 38 0.0018
820 HAEMOPTYSIS 50 0.0018
821 STAPHYLOCOCCAL INFECTION 59 0.0018
822 CARDIAC FAILURE 143 0.0018
823 DYSPHONIA 104 0.0018
824 HEMIPARESIS 30 0.0018
825 EAR INFECTION 47 0.0018
826 VENTRICULAR TACHYCARDIA 29 0.0018
827 ADVERSE DRUG REACTION 157 0.0017
828 FLATULENCE 99 0.0017
829 GLOSSODYNIA 39 0.0017
830 IMPAIRED QUALITY OF LIFE 25 0.0017
831 THROAT TIGHTNESS 47 0.0017
832 MEDICATION ERROR 96 0.0017
833 INTESTINAL OBSTRUCTION 65 0.0017
834 ANXIETY 488 0.0017
835 PRODUCT AVAILABILITY ISSUE 39 0.0017
836 WEIGHT INCREASED 381 0.0017
837 SYSTEMIC LUPUS ERYTHEMATOSUS 60 0.0017
838 LIP SWELLING 56 0.0017
839 ISCHAEMIC STROKE 30 0.0017
840 DRY SKIN 222 0.0017
841 HYPERKALAEMIA 58 0.0017
842 INJURY 115 0.0016
843 ROAD TRAFFIC ACCIDENT 68 0.0016
844 GALLBLADDER DISORDER 29 0.0016
845 MIDDLE INSOMNIA 30 0.0016
846 MUSCLE TWITCHING 37 0.0016
847 DISEASE RECURRENCE 76 0.0016
848 DYSARTHRIA 60 0.0016
849 FUNGAL INFECTION 53 0.0016
850 CARDIAC ARREST 130 0.0016
851 SLEEP APNOEA SYNDROME 30 0.0016
852 BLOOD GLUCOSE ABNORMAL 29 0.0016
853 NERVOUSNESS 82 0.0016
854 FAECES DISCOLOURED 34 0.0016
855 BLOOD CREATINE PHOSPHOKINASE INCREASED 45 0.0016
856 MULTI-ORGAN FAILURE 27 0.0016
857 CLOSTRIDIUM DIFFICILE INFECTION 34 0.0016
858 CONVULSION 89 0.0016
859 RASH ERYTHEMATOUS 74 0.0015
860 GLYCOSYLATED HAEMOGLOBIN INCREASED 39 0.0015
861 COGNITIVE DISORDER 72 0.0015
862 INTENTIONAL PRODUCT USE ISSUE 135 0.0015
863 THERAPY NON-RESPONDER 69 0.0015
864 SKIN CANCER 33 0.0015
865 PNEUMONIA ASPIRATION 38 0.0015
866 RASH MACULAR 53 0.0015
867 MEMORY IMPAIRMENT 208 0.0015
868 CHRONIC KIDNEY DISEASE 115 0.0015
869 CARDIAC FAILURE CONGESTIVE 121 0.0015
870 ANGINA PECTORIS 43 0.0015
871 EYE IRRITATION 86 0.0015
872 EYE PRURITUS 50 0.0015
873 PRODUCT ADMINISTRATION ERROR 30 0.0015
874 ILL-DEFINED DISORDER 90 0.0015
875 FLUID RETENTION 75 0.0015
876 SNEEZING 33 0.0015
877 GASTROINTESTINAL HAEMORRHAGE 122 0.0015
878 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 103 0.0014
879 MOOD SWINGS 46 0.0014
880 SKIN FISSURES 28 0.0014
881 RASH GENERALISED 37 0.0014
882 MENTAL DISORDER 62 0.0014
883 ABDOMINAL PAIN LOWER 36 0.0014
884 URTICARIA 235 0.0014
885 CARDIAC DISORDER 131 0.0014
886 CYTOKINE RELEASE SYNDROME 28 0.0014
887 EMOTIONAL DISORDER 43 0.0014
888 SEIZURE 161 0.0014
889 AGITATION 102 0.0014
890 LUNG NEOPLASM MALIGNANT 57 0.0014
891 SKIN EXFOLIATION 117 0.0014
892 ASTHMA 153 0.0014
893 BLOOD GLUCOSE INCREASED 254 0.0013
894 HAEMATOCHEZIA 74 0.0013
895 BRADYCARDIA 71 0.0013
896 HEPATIC CIRRHOSIS 25 0.0013
897 CORONARY ARTERY DISEASE 40 0.0013
898 RESPIRATORY DISTRESS 36 0.0013
899 PRODUCT PRESCRIBING ERROR 31 0.0013
900 PULMONARY HYPERTENSION 27 0.0013
901 PRURITUS GENERALISED 28 0.0013
902 HERNIA 25 0.0013
903 CEREBROVASCULAR ACCIDENT 219 0.0013
904 CHOKING 25 0.0013
905 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 70 0.0013
906 PAIN OF SKIN 34 0.0013
907 IRRITABLE BOWEL SYNDROME 27 0.0013
908 MYOCARDIAL INFARCTION 217 0.0012
909 TREATMENT FAILURE 103 0.0012
910 ERUCTATION 24 0.0012
911 PANCREATITIS 65 0.0012
912 ANHEDONIA 32 0.0012
913 CEREBRAL HAEMORRHAGE 43 0.0012
914 FLUSHING 122 0.0012
915 MENTAL IMPAIRMENT 29 0.0012
916 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 215 0.0012
917 NASAL CONGESTION 70 0.0012
918 THERAPEUTIC PRODUCT EFFECT DECREASED 53 0.0012
919 BLISTER 66 0.0012
920 LACTIC ACIDOSIS 38 0.0012
921 HEPATIC CANCER 28 0.0012
922 HAEMORRHAGE 121 0.0012
923 PROCEDURAL PAIN 32 0.0012
924 TOXICITY TO VARIOUS AGENTS 192 0.0011
925 PSYCHOTIC DISORDER 33 0.0011
926 HALLUCINATION 82 0.0011
927 PRODUCT USE ISSUE 203 0.0011
928 EMOTIONAL DISTRESS 130 0.0011
929 DYSKINESIA 43 0.0011
930 WHEEZING 62 0.0010
931 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 30 0.0010
932 CARDIOVASCULAR DISORDER 26 0.0010
933 PRODUCT DOSE OMISSION IN ERROR 29 0.0010
934 ENCEPHALOPATHY 25 0.0010
935 THERAPEUTIC RESPONSE DECREASED 61 0.0010
936 DRUG INEFFECTIVE 1320 0.0010
937 SEDATION 26 0.0010
938 DEPRESSED LEVEL OF CONSCIOUSNESS 39 0.0010
939 TYPE 2 DIABETES MELLITUS 33 0.0010
940 RENAL INJURY 29 0.0010
941 PRODUCT DOSE OMISSION ISSUE 280 0.0010
942 HYPOGLYCAEMIA 46 0.0009
943 ADVERSE EVENT 84 0.0009
944 THERAPY INTERRUPTED 65 0.0009
945 UNDERDOSE 65 0.0009
946 DISTURBANCE IN ATTENTION 48 0.0009
947 FREQUENT BOWEL MOVEMENTS 24 0.0009
948 TREATMENT NONCOMPLIANCE 48 0.0009
949 BLOOD GLUCOSE DECREASED 42 0.0009
950 THERAPEUTIC RESPONSE SHORTENED 29 0.0009
951 BREAST CANCER FEMALE 23 0.0009
952 CONTRAINDICATED PRODUCT ADMINISTERED 26 0.0009
953 THERAPEUTIC RESPONSE UNEXPECTED 38 0.0008
954 INTENTIONAL DOSE OMISSION 24 0.0008
955 UNEVALUABLE EVENT 62 0.0008
956 EPILEPSY 25 0.0008
957 ECZEMA 42 0.0008
958 THERAPY CESSATION 41 0.0008
959 ANGER 27 0.0008
960 ANAPHYLACTIC REACTION 44 0.0008
961 ANGIOEDEMA 34 0.0008
962 ACCIDENTAL OVERDOSE 28 0.0008
963 IRRITABILITY 46 0.0008
964 INJECTION SITE BRUISING 58 0.0007
965 SKIN IRRITATION 33 0.0007
966 HOSPITALISATION 107 0.0007
967 PANIC ATTACK 25 0.0007
968 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 48 0.0007
969 COLITIS ULCERATIVE 29 0.0006
970 MULTIPLE SCLEROSIS 31 0.0006
971 AGGRESSION 31 0.0006
972 PSORIATIC ARTHROPATHY 25 0.0006
973 INCORRECT DOSE ADMINISTERED 138 0.0006
974 PRODUCT DOSE OMISSION 36 0.0006
975 INTENTIONAL PRODUCT MISUSE 47 0.0005
976 INJECTION SITE PRURITUS 34 0.0005
977 INJECTION SITE REACTION 33 0.0005
978 INJECTION SITE ERYTHEMA 59 0.0005
979 INJECTION SITE PAIN 143 0.0005
980 ACNE 34 0.0004
981 BLADDER CANCER 26 0.0004
982 MATERNAL EXPOSURE DURING PREGNANCY 39 0.0004
983 INJECTION SITE SWELLING 33 0.0004
984 SUICIDAL IDEATION 38 0.0004
985 INJECTION SITE HAEMORRHAGE 32 0.0004
986 SKIN BURNING SENSATION 28 0.0004
987 DEVICE MALFUNCTION 26 0.0004
988 PSORIASIS 46 0.0004
989 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 63 0.0003
990 DRUG DOSE OMISSION 49 0.0003
991 OVERDOSE 60 0.0003
992 NO ADVERSE EVENT 49 0.0003
993 PRODUCT QUALITY ISSUE 27 0.0002